期刊文献+

伏立康唑致严重水肿 被引量:2

Sever edema caused by voriconazole
原文传递
导出
摘要 1例54岁男性患者因肝脓肿住院,因长期使用亚胺培南/西司他丁治疗,预防肠道真菌感染予口服伏立康唑200mg qd治疗,用药3d后患者出现全身水肿及多浆膜腔积液.排除其他可能引起水肿的因素,考虑水肿为伏立康唑所致.遂停用伏立康唑,同时对症处理,患者水肿消退. A 54-year-old man was admitted to hospital because of liver abscess. The patient received treatment with imipenem/cilastain. Oralvoriconazole(200mg qd) treament was performed for prevention of Intestinal tract fungal infection. Three days later, the patient developed edema andpolyserositis. Excluded some factors that may cause edema, voriconazole was considered to be the agent for edema. Voriconazole was discontinued,meanwhile symptomatic therapy was given, the patient’s edema was disappeared.
作者 李搀 韩仰光
出处 《中华临床医师杂志(电子版)》 CAS 2016年第4期141-141,共1页 Chinese Journal of Clinicians(Electronic Edition)
关键词 伏立康唑 不良反应 水肿 voriconazole adverse reactions edema
  • 相关文献

参考文献7

二级参考文献30

  • 1席玉胜,魏春霞,孟猛,谢潮鑫,陈莉文.依曲康唑对院内继发深部真菌感染的预防作用[J].中国药师,2006,9(6):548-549. 被引量:1
  • 2Shorr AF, Chung K, Jackson WL, et al. Fluconazole prophylaxis in critically ill surgical patients:a meta-analysis. Crit Care Med,2005,33 : 1928-1935.
  • 3Yamaguchi H, Ikemoto H, Watanabe K, et al. Fluconazole monotherapy for cryptococcosis in non-AIDS patients. Eur J Clin Microbiol Infect Dis, 1996,15:787-792.
  • 4Winston D J, Maziarz RT, Chandrasekar PH, et al. Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial. Ann Intern Meal,2003,138:705-713.
  • 5Caillot D, Bassaris H, McGeer A, et al. Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary asperginosis in patients with hematologic malignancies, chronic granulomatous disease,or AIDS. Clin Infect Dis ,2001,33: e83-e90.
  • 6Denning DW, Ribaud P, Milpied N, et al. Eigcacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis,2002,34:563-571.
  • 7Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med,2002,347:408-415.
  • 8Mora-Duarte J,Betts R,Rotstein C,et al. Comparison of caspofungin and amphoteficin B for invasive candidiasis. N Engl J Med, 2002,347:2020-2029.
  • 9Denning DW. Echinocandin antifungal drugs. Lancet, 2003,362 :1142-1151.
  • 10Ostrosky-Zeichner L, Mart KA, Rex JH, et al. Amphotericin B : time for a new "gold standard". Clin Infect Dis ,2003,37:415-425.

共引文献49

同被引文献15

引证文献2

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部